MD291Y - Method for predicting the development of adverse effects in hearing aids - Google Patents

Method for predicting the development of adverse effects in hearing aids Download PDF

Info

Publication number
MD291Y
MD291Y MDS20100154A MDS20100154A MD291Y MD 291 Y MD291 Y MD 291Y MD S20100154 A MDS20100154 A MD S20100154A MD S20100154 A MDS20100154 A MD S20100154A MD 291 Y MD291 Y MD 291Y
Authority
MD
Moldova
Prior art keywords
adverse effects
predicting
occurrence
development
hearing aids
Prior art date
Application number
MDS20100154A
Other languages
Romanian (ro)
Inventor
Ion Ababii
Sergiu Parii
Anghelina Chiaburu
Constantin Jucovschi
Original Assignee
Universitatea De Stat De Medicina Si Farmacie "Nicolae Testemitanu" Din Republica Moldova
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Universitatea De Stat De Medicina Si Farmacie "Nicolae Testemitanu" Din Republica Moldova filed Critical Universitatea De Stat De Medicina Si Farmacie "Nicolae Testemitanu" Din Republica Moldova
Priority to MDS20100154A priority Critical patent/MD291Z/en
Publication of MD291Y publication Critical patent/MD291Y/en
Publication of MD291Z publication Critical patent/MD291Z/en

Links

Landscapes

  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
  • Prostheses (AREA)

Abstract

Inventia se refera la medicina, in special la otorinolaringologie. Esenta inventiei consta in aceea ca metoda de pronostic al aparitiei efectelor adverse la protezarea auditiva include examenul clinic si paraclinic ce releva urmatorii parametri: varsta pacientului (VP), infectiile suportate (FS), evolutia surditatii (ES), pragul auditiv in limitele 0...120 dB (PA), indicele de articulare (IA), apoi se calculeaza functia discriminanta (F) conform formulei:F = -7.927 + 0.144 · VP – 0.476 · FS – 0.975 · ES + 0.073 · PA + 0.065 · IA,si in cazul in care F>0 se prognozeaza lipsa riscului de aparitie a efectelor adverse, iar cand F<0 - riscul aparitiei efectelor adverse.The invention relates to medicine, in particular to otolaryngology. The essence of the invention is that the method for predicting the occurrence of adverse effects on the hearing prosthesis includes the clinical and paraclinical examination that reveals the following parameters: age of the patient (VP), infections supported (FS), evolution of deafness (ES), hearing threshold within limits 0. ..120 dB (PA), the joint index (IA), then calculate the discriminating function (F) according to the formula: F = -7.927 + 0.144 · VP - 0.476 · FS - 0.975 · ES + 0.073 · PA + 0.065 · IA , and if F> 0 is predicted the absence of the risk of occurrence of adverse effects, and when F <0 - the risk of occurrence of adverse effects.

MDS20100154A 2010-07-19 2010-07-19 Method for predicting the development of adverse effects in hearing aids MD291Z (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MDS20100154A MD291Z (en) 2010-07-19 2010-07-19 Method for predicting the development of adverse effects in hearing aids

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MDS20100154A MD291Z (en) 2010-07-19 2010-07-19 Method for predicting the development of adverse effects in hearing aids

Publications (2)

Publication Number Publication Date
MD291Y true MD291Y (en) 2010-11-30
MD291Z MD291Z (en) 2011-07-31

Family

ID=45815233

Family Applications (1)

Application Number Title Priority Date Filing Date
MDS20100154A MD291Z (en) 2010-07-19 2010-07-19 Method for predicting the development of adverse effects in hearing aids

Country Status (1)

Country Link
MD (1) MD291Z (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD732Z (en) * 2013-04-12 2014-09-30 Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова Method for determining the maximum speech intelligibility index

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD1041C2 (en) * 1997-02-13 1999-06-30 Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова Method for prognostication of middle ear latent diseases to children in the first year of life
MD1039C2 (en) * 1997-02-13 1999-06-30 Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова Diagnosis method of latent inflammatory affections of the midlle ear to children during their first year of life
  • 2010

Also Published As

Publication number Publication date
MD291Z (en) 2011-07-31

Similar Documents

Publication Publication Date Title
Maenz et al. Ocular toxoplasmosis past, present and new aspects of an old disease
FR24C1024I1 (en) COMBINATIONS OF DOLUTEGRAVIR AND LAMIVUDINE FOR THE TREATMENT OF HIV INFECTION
CY1121310T1 (en) USE OF SILICONE ZIRCON FOR THE TREATMENT OF HYPERKALIAEMIA
MY186986A (en) Compositions and methods of use of phorbol esters
AR081166A1 (en) ANGIOGENESIS FOR THE USE OF PLACENTARY MOTHER CELLS
IN2013CN07995A (en)
EA201000897A1 (en) COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS FOR REDUCING URIC ACID LEVEL
EP2569330A4 (en) CHLOROTOXINE VARIANTS, CONJUGATES, AND METHODS OF USE THEREOF
EP2847207A4 (en) PREPARATIONS OF HYDROPHOBIC THERAPEUTIC AGENTS, METHODS OF MANUFACTURE AND USE THEREOF
MD291Y (en) Method for predicting the development of adverse effects in hearing aids
EP3952787A4 (en) PATIENT CANAL ARTERIAL STENT PROSTHESIS
GB2520889A (en) Patient reported outcome instrument
EP2941437A4 (en) PREPARATIONS OF HYDROPHOBIC THERAPEUTIC AGENTS, METHODS OF MAKING AND USING THEM
EP2742896A4 (en) TRÉPAN, TRÉPAN COVER AND OS SURGICAL SURGICAL INSTRUMENT AUTOLOGOUS EMPLOYER
CN104939871B (en) A kind of prominent protection guide plate of ankylosis of temporo-mandibular joint osteotomy condyle
NZ624714A (en) Methods for treating gout in patient subpopulations
陳克耀 et al. Serological survey of equine piroplasmosis, equine granulocytic anaplasmosis, and equine Lyme disease in Taiwan
Sulaiman CD4 lymphocyte count: A barometer for HIV/AIDS management
EP2986279A4 (en) PULVERULENT COMPOSITION FOR THE TREATMENT OF MAMMALIAN HEARING CHANNEL DISORDER AND USE THEREOF
RU2700631C1 (en) Method of estimating the area of eukaryotic cells adhered on opaque surfaces
Yavasoglu et al. Penile ulcer ATRA related in patient with acute promyelocytic leukemia
Dumić-Čule et al. Mini skull collection: recent measurements report
O'grady et al. Rethinking mandatory HIV testing
UA69256U (en) method for pre-planning the amount of surgical correction of kyphotic deformity in ankylosing spondylitis
Taira et al. EFFECTIVENESS OF MICROSCOPIC VISIONON REMOVAL OF FRACTURED PROSTHETIC ABUTMENTS IN OSSEOINTEGRATED IMPLANTS: A CLINICAL REPORT

Legal Events

Date Code Title Description
KA4Y Short-term patent lapsed due to non-payment of fees (with right of restoration)